Idorsia (Switzerland) Performance
| IDIA Stock | CHF 0.76 0.08 9.52% |
The company retains a Market Volatility (i.e., Beta) of 0.72, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Idorsia's returns are expected to increase less than the market. However, during the bear market, the loss of holding Idorsia is expected to be smaller as well. At this point, Idorsia has a negative expected return of -1.53%. Please make sure to check out Idorsia's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if Idorsia performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Idorsia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 101.4 M |
Idorsia |
Idorsia Relative Risk vs. Return Landscape
If you would invest 220.00 in Idorsia on August 29, 2024 and sell it today you would lose (144.00) from holding Idorsia or give up 65.45% of portfolio value over 90 days. Idorsia is generating negative expected returns and assumes 4.7659% volatility on return distribution over the 90 days horizon. Simply put, 42% of stocks are less volatile than Idorsia, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Idorsia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Idorsia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Idorsia, and traders can use it to determine the average amount a Idorsia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.322
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IDIA |
Estimated Market Risk
| 4.77 actual daily | 42 58% of assets are more volatile |
Expected Return
| -1.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.32 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Idorsia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Idorsia by adding Idorsia to a well-diversified portfolio.
Idorsia Fundamentals Growth
Idorsia Stock prices reflect investors' perceptions of the future prospects and financial health of Idorsia, and Idorsia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Idorsia Stock performance.
| Return On Equity | -64.61 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (8.25) % | |||
| Current Valuation | 2.88 B | |||
| Shares Outstanding | 187.56 M | |||
| Price To Book | 27.65 X | |||
| Price To Sales | 48.84 X | |||
| Revenue | 97.1 M | |||
| EBITDA | (783.09 M) | |||
| Cash And Equivalents | 811.85 M | |||
| Cash Per Share | 6.19 X | |||
| Total Debt | 1.13 B | |||
| Debt To Equity | 112.20 % | |||
| Book Value Per Share | (3.72) X | |||
| Cash Flow From Operations | (859.11 M) | |||
| Earnings Per Share | (4.26) X | |||
| Total Asset | 904.18 M | |||
About Idorsia Performance
Evaluating Idorsia's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Idorsia has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Idorsia has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.Things to note about Idorsia performance evaluation
Checking the ongoing alerts about Idorsia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Idorsia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Idorsia generated a negative expected return over the last 90 days | |
| Idorsia has some characteristics of a very speculative penny stock | |
| Idorsia has high historical volatility and very poor performance | |
| Idorsia has high likelihood to experience some financial distress in the next 2 years | |
| Idorsia has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 97.1 M. Net Loss for the year was (827.9 M) with loss before overhead, payroll, taxes, and interest of (292.5 M). | |
| Idorsia has accumulated about 811.85 M in cash with (859.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 36.0% of the company shares are held by company insiders |
- Analyzing Idorsia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Idorsia's stock is overvalued or undervalued compared to its peers.
- Examining Idorsia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Idorsia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Idorsia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Idorsia's stock. These opinions can provide insight into Idorsia's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.